DP-38P BIO-PROBE DISPOSABLE INSERT 95134

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06,07 report with the FDA on 1997-11-02 for DP-38P BIO-PROBE DISPOSABLE INSERT 95134 manufactured by Medtronic Bio-medicus, Inc..

Event Text Entries

[112111] Hospital reported that 39 hours into an extracorporeal membrane oxygenation case (ecmo), blood leakage was noticed at one of the dp-38p bio-probe tubing connectors. The device was removed from the circuit and replaced with a second bio-probe insert. Case was continued with no effect to the pt.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2124837-1997-00025
MDR Report Key131187
Report Source05,06,07
Date Received1997-11-02
Date of Report1997-11-02
Date of Event1997-09-26
Date Facility Aware1997-10-24
Report Date1997-11-02
Date Mfgr Received1997-10-28
Date Added to Maude1997-11-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDP-38P BIO-PROBE DISPOSABLE INSERT
Generic NamePROBE, BLOOD FLOW, EXTRACORPOREAL
Product CodeDPT
Date Received1997-11-02
Returned To Mfg1997-10-28
Model NumberDP-38P
Catalog Number95134
Lot NumberUNK
ID Number*
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeUNKNOWN
Device Eval'ed by MfgrY
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key128234
ManufacturerMEDTRONIC BIO-MEDICUS, INC.
Manufacturer Address9600 WEST 76TH ST. EDEN PRAIRIE MN 55344 US
Baseline Brand NameBIO-PROBE DISPOSABLE INSERT
Baseline Generic NameEXTRAVASCULAR BLOOD FLOW PROBE
Baseline Model NoDP-38
Baseline Catalog No95133
Baseline IDBIO-PROBE FLOW
Baseline Device FamilyBIO-PROBE
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]60
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK830858
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 1997-11-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.